The phase 1/2 study will assess next-generation immunotherapy alone and in combination with an immune checkpoint inhibitor in ...

Investigators said patients experienced adverse effects in line with those expected for myeloablative conditioning with ...

Anocca has submitted its first clinical trial application (CTA) to the European Medicines Agency (EMA) for conducting the ...

Neoantigen DNA vaccines are safe and capable of inducing neoantigen-specific immune responses in patients with triple-negative breast cancer.

Pluripotent stem cells are cells that have the capacity to self-renew by dividing and to develop into the three primary germ cell layers of the early embryo and therefore into all cells of the ...

The approval is supported by data from the COBLT study, FDA dockets and public information, and an observational database.

Every three minutes, an American is diagnosed with some type of blood cancer and every nine minutes, an American is lost.

An airman and a Ramstein High School junior teamed up to register potential bone marrow donors for Salute to Life.

The BLA approval is supported by data from the COBLT study, FDA dockets and public information, and from a RegeneCyte observational database.

The following is a summary of "Activation of peripheral leukocyte migration before spontaneous labor at term," published in ...

First human trial of stem-cell-derived corneal transplants for LSCD shows vision improvement, suggesting a safe and effective ...

San Francisco–based Ossium Health has carried out three transplants for cancer patients using stem cells from deceased donors’ bone marrow in recent months.